Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

203 Dual targeting of uPAR and MICA/B with multiplexed-engineered CAR T cells offers a unique therapeutic strategy in fibrotic disease

  • Hui-Yi Chu1
  • Bahram Valamehr2
  • Soheila Shirinbak3
  • Eigen Peralta2
  • Thomas Dailey2
  • Miguel Meza3
  • Masanao Tsuda2
  • Bi-Huei Yang2
  • Olena A Kolesnichenko1
  • Sean P Sherman1
  • Alma Gutierrez1
  • Alex J Garcia1
2 more authors
  • Tom T Lee1
  • Martin P Hosking1
  1. 1Fate Therapeutics, Inc., San Diego, CA, USA
  2. 21Fate Therapeutics, San Diego, CA, USA
  3. 31Fate Therapeutics, Inc., San Diego, CA, USA
Open at sourcePDFDOICite

Related

  1. Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson’s disease
    Wenwen Chen, Yejing Zhang, Xinrui Zhou +4
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationNeurologyCell PressCrossrefEurope PMC
  2. Targeting Endoplasmic Reticulum Stress with Tauroursodeoxycholic Acid: A Potential Therapeutic Strategy for Allergic Airway Diseases
    Yining Han
    Biomedicine HubPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  3. G-quadruplex targeting by CX-5461 as a novel therapeutic strategy in testicular germ cell tumors
    R. Islam, A. Liesen, C. S. R. Roque +2
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  4. Single-cell RNA Sequencing Analysis Reveals That Targeting PLG–PLGRKT Signaling-mediated Pro-fibrotic Scar-associated Macrophages Ameliorates Liver Fibrosis in Biliary Atresia
    Xin Li, Tengfei Li, Shaowen Liu +9
    Journal of Clinical and Translational HepatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Chronic Inflammation, Fibrotic Remodeling, and Regenerative Failure in Duchenne Muscular Dystrophy: Mechanisms and Therapeutic Opportunities
    Jie Shi, Jiao Yang
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{chu2026dual,
  title = {{203 Dual targeting of uPAR and MICA/B with multiplexed-engineered CAR T cells offers a unique therapeutic strategy in fibrotic disease}},
  author = {Hui-Yi Chu and Bahram Valamehr and Soheila Shirinbak and Eigen Peralta and Thomas Dailey and Miguel Meza and Masanao Tsuda and Bi-Huei Yang and Olena A Kolesnichenko and Sean P Sherman and Alma Gutierrez and Alex J Garcia and Tom T Lee and Martin P Hosking},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0203},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0203},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 203 Dual targeting of uPAR and MICA/B with multiplexed-engineered CAR T cells offers a unique therapeutic strategy in fibrotic disease
AU  - Hui-Yi Chu
AU  - Bahram Valamehr
AU  - Soheila Shirinbak
AU  - Eigen Peralta
AU  - Thomas Dailey
AU  - Miguel Meza
AU  - Masanao Tsuda
AU  - Bi-Huei Yang
AU  - Olena A Kolesnichenko
AU  - Sean P Sherman
AU  - Alma Gutierrez
AU  - Alex J Garcia
AU  - Tom T Lee
AU  - Martin P Hosking
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0203
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0203
SN  - 2051-1426
ER  -